NASDAQ Stocks Gained Large Volume (SONS, PGRX, UNXL, PEIX, HPTX)

Los Angelas, CA -- (SBWIRE) -- 02/05/2013 -- Sonus Networks, Inc. (NASDAQ:SONS) shares surged 17 percent on over 10 million shares traded Monday, which was nearly five-times the average daily volume. Oracle's purchase of Acme Packet for $2.1 billion has raised speculation that other companies in similar fields may become targets.

Can SONS Continue To Move Higher? Find Out Here

Prospect Global Resources Inc (NASDAQ:PGRX) shares jumped 26.24% and closed at $1.78 in the last trading session. The company announced that it will host an analyst and investor day on Tuesday, February 5, 2013, in New York City. The meeting, to be held at 12:30 p.m. at the St. Regis Hotel, 2 East 55th Street, will be open to the public, including research analysts, institutional and retail investors, and members of the media.

Will The PGRX Split Boost Share Price Among Huge Volatility? Find Out Here

Uni-Pixel Inc (NDA) (NASDAQ:UNXL) shares increased 3.06% and closed at $13.83 in yesterday’s session. The company will hold a conference call on Tuesday, February 26, 2013 at 4:30 p.m. Eastern time to discuss the fourth quarter and full year ended December 31, 2012. Financial results will be issued in a press release prior to the call.

Where Is Uni-Pixel Headed Exactly After Achieving This Milestone? Find Out Here

Pacific Ethanol Inc (NASDAQ:PEIX) shares gained 4.14% and closed at $0.398 in yesterday’s session. The company, on Jan. 22, has contracted to install Edeniq Inc.’s Cellunator technology at its 60 MMgy Stockton, Calif., ethanol plant. “There’s not a huge amount of retrofitting and we should be able to have that online by the middle of the second quarter,” said Paul Koehler, vice president of business development.

Is PEIX Showing Any Sign of Buy At The Current Market Price? Find Out Here

Hyperion Therapeutics Inc. (NASDAQ:HPTX) shares hit a new all-time high of $23.47 after soaring over 20 percent on more than six-times the average daily volume Monday. The company on Friday reported the FDA has approved RAVICTI for the treatment of Urea Cycle Disorders.

Can HPTX Extend Rally? Find Out Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com